ELISE MARTINEZ: Open Payments
NPI 1457823361 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$330 in 15 payments from 5 companies in 2025. Trend: 2023 $27 · 2024 $65 · 2025 $330
Food & beverage: $330
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $125 |
| Amgen Inc. | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Dexcom, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: CAPLYTA, OTEZLA, AIRSUPRA, Dexcom G6 Transmitter, GVOKE HYPOPEN.
Industry payments across CA — which companies pay providers there.
